A 6000% price rise in ten years? Big corporations overcharge for your medicine and rip off the NHS.

NHS Not Safe
Support us and go ad-free

The Competition and Markets Authority (CMA) has ruled that Canadian pharmaceutical company Concordia has effectively been ripping off the NHS. Since 2007, Concordia has raised the price of a life-changing drug, for which it was the only supplier, by 6000%. The CMA’s ruling therefore raises deeper questions about the role of the marketplace in our public services.

Lack of competition

Until last year, Concordia was the only global supplier of Liothryronine, a drug used to treat hypothyroidism. Usually affecting those over the age of 40, the symptoms of hypothyroidism can be debilitating. They include weight gain, breathlessness and mobility issues.

When Concordia first sold its treatment to the NHS, in 2007, it cost £4.46 a pack. By 2017, this had increased to a staggering £258.19. For a single tablet, this equated to a rise from 16p to £9.22. Yet the cost of producing the drug remained broadly the same during that period.

CMA Chief Executive Andrea Coscelli said:

Pharmaceutical companies which abuse their position and overcharge for drugs are forcing the NHS – and the UK taxpayer – to pay over the odds for important medical treatments. We allege that Concordia used its market dominance in the supply of Liothyronine tablets to do exactly that.

Nothing new…

The practice is nothing new for companies like Concordia. In October 2016, its CEO Mark Thompson resigned amid accusations of “aggressive price hiking”. In the past, giant US firms like Pfizer and Flynn Pharma provoked similar scandals. British company GlaxoSmithKline was fined heavily for market rigging in January 2016. Such companies wield huge power. Against that, the underfunded and asset-stripped NHS can do little to protect itself, or its patients.

A wrong-headed approach?

The CMA judgement is welcome, but provides no long-term solutions, as big companies will continue to abuse their position. Pharmaceutical corporations, like all corporations, aim solely to maximise profit for shareholders. This is the prevailing system. But it is not a sensible approach to healthcare.

Read on...

Public services should be run for people, not profit.

Get Involved!

– Read more Canary stories about the NHS here.

Join us so we can continue to hold the powerful to account.

Featured image via Flickr

We know everyone is suffering under the Tories - but the Canary is a vital weapon in our fight back, and we need your support

The Canary Workers’ Co-op knows life is hard. The Tories are waging a class war against us we’re all having to fight. But like trade unions and community organising, truly independent working-class media is a vital weapon in our armoury.

The Canary doesn’t have the budget of the corporate media. In fact, our income is over 1,000 times less than the Guardian’s. What we do have is a radical agenda that disrupts power and amplifies marginalised communities. But we can only do this with our readers’ support.

So please, help us continue to spread messages of resistance and hope. Even the smallest donation would mean the world to us.

Support us

Comments are closed